Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06891352 · ClinicalTrials.gov registry record · NA
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
A NA study of Obesity and Overweight, sponsored by Salk Institute for Biological Studies.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06891352: Recruiting NA study of Obesity and Overweight, sponsored by Salk Institute for Biological Studies.
NCT06891352 is a NA study of Obesity and Overweight that is actively recruiting participants, run by Salk Institute for Biological Studies. The registered enrollment target is 180 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06891352, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by Salk Institute for Biological Studies.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
In this randomized controlled trial, the investigators will assess the health impacts of optimizing the timing of dietary consumption in nurses and nursing assistants who work night shifts, have a habitual eating window of 14 hours or more, and elevated weight. Participants will be randomized to one of three groups: (1) dietary monitoring, (2) dietary monitoring plus 10-hour daytime time-restricted eating (TRE), or (3) TRE with a low-glycemic snack during night shifts. The study includes a 2-week screening/baseline health assessment, with follow-up health assessments at 3-, 6- (primary outcome), and 12 months.
Primary Outcome
Total Body Fat Mass (kg) assessed by DXA
Conditions Studied
Interventions
- BEHAVIORAL Dietary Monitoring
- BEHAVIORAL Time-Restricted Eating (TRE)
- BEHAVIORAL Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS)
Study Locations (1)
California
- University of California San Diego Altman Clinical and Translational Research Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-06-02 |
| Est. Completion | 2029-03-03 |
| Phase | NA |
What NCT06891352 shows while recruiting
NCT06891352 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower).
The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Dietary Monitoring is the first listed.
NCT06891352 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06891352 about?
NCT06891352 is a clinical study titled "Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers". In this randomized controlled trial, the investigators will assess the health impacts of optimizing the timing of dietary consumption in nurses and nursing assistants who work night shifts, have a habitual eating window of 14 hours or more, and elevated weight. Participants will be randomized to one...
What is the current status of trial NCT06891352?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-06-02. Estimated completion is 2029-03-03.
What conditions does trial NCT06891352 study?
This clinical trial studies the following conditions: Obesity, Overweight, Time-restricted Eating, Night Shift Work.
What interventions are being tested in trial NCT06891352?
The interventions under investigation include: Dietary Monitoring (BEHAVIORAL), Time-Restricted Eating (TRE) (BEHAVIORAL), Time-Restricted Eating with a Low-Glycemic Snack (TRE-LGS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06891352?
This trial is sponsored by Salk Institute for Biological Studies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06891352 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06891352's enrollment target sits among peer trials
180 339th of 1053 higher than 709 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI